Found: 23
Select item for more details and to access through your institution.
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5763, doi. 10.1007/s10072-022-06154-0
- By:
- Publication type:
- Article
Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 489, doi. 10.1007/s10072-020-04670-5
- By:
- Publication type:
- Article
Diaphragmatic myoclonus due to SARS-CoV-2 infection.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3471, doi. 10.1007/s10072-020-04766-y
- By:
- Publication type:
- Article
OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of headache disorders in the Emergency Department setting.
- Published in:
- Neurological Sciences, 2015, v. 36, n. 7, p. 1153, doi. 10.1007/s10072-015-2148-7
- By:
- Publication type:
- Article
Erratum to: Management of headache disorders in the Emergency Department setting.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Reduction in retinal nerve fiber layer thickness in migraine patients.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 6, p. 841, doi. 10.1007/s10072-012-1103-0
- By:
- Publication type:
- Article
Immigration and neurological diseases: a longitudinal study in an acute neurological care.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 5, p. 979, doi. 10.1007/s10072-011-0868-x
- By:
- Publication type:
- Article
Cerebrovascular risk factors and MRI abnormalities in migraine.
- Published in:
- Neurological Sciences, 2008, v. 29, p. 144, doi. 10.1007/s10072-008-0907-4
- By:
- Publication type:
- Article
Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00678
- By:
- Publication type:
- Article
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.
- Published in:
- European Neurology, 2023, v. 86, n. 2, p. 135, doi. 10.1159/000527674
- By:
- Publication type:
- Article
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia?
- Published in:
- Brain: A Journal of Neurology, 2007, v. 130, n. 1, p. 134
- By:
- Publication type:
- Article
Functional serotonin 5–HTTLPR polymorphism is a risk factor for migraine with aura.
- Published in:
- Journal of Headache & Pain, 2005, v. 6, n. 4, p. 182, doi. 10.1007/s10194-005-0179-9
- By:
- Publication type:
- Article
Photophobia and migraine outcome during treatment with galcanezumab.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2022.1088036
- By:
- Publication type:
- Article
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 2848, doi. 10.1007/s00415-021-10946-3
- By:
- Publication type:
- Article
An observational study on monoclonal antibodies against calcitonin‐gene‐related peptide and its receptor.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 6, p. 1764, doi. 10.1111/ene.15761
- By:
- Publication type:
- Article
Odor Identification Deficit Predicts Clinical Conversion from Mild Cognitive Impairment to Dementia Due to Alzheimer's Disease.
- Published in:
- Archives of Clinical Neuropsychology, 2013, v. 28, n. 5, p. 391, doi. 10.1093/arclin/act032
- By:
- Publication type:
- Article
Functional Connectivity Networks in Asymptomatic and Symptomatic DYT1 Carriers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia.
- Published in:
- Movement Disorders, 2006, v. 21, n. 10, p. 1782, doi. 10.1002/mds.21056
- By:
- Publication type:
- Article
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.
- Published in:
- Neurology International, 2023, v. 15, n. 1, p. 273, doi. 10.3390/neurolint15010017
- By:
- Publication type:
- Article
Where SUNCT Contacts TN: A Case Report.
- Published in:
- Headache: The Journal of Head & Face Pain, 2013, v. 53, n. 9, p. 1492, doi. 10.1111/head.12007
- By:
- Publication type:
- Article
Endothelial Nitric Oxide Synthase (Glu298Asp) Polymorphism is an Independent Risk Factor for Migraine with Aura.
- Published in:
- Headache: The Journal of Head & Face Pain, 2006, v. 46, n. 10, p. 1575, doi. 10.1111/j.1526-4610.2006.00614.x
- By:
- Publication type:
- Article
Investigating the Association Between Notch3 Polymorphism and Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2006, v. 46, n. 2, p. 317, doi. 10.1111/j.1526-4610.2006.00344.x
- By:
- Publication type:
- Article